Jarushka Naidoo, Professor of Medical Oncology at RCSI College of Drugs and Well being Sciences, shared on X:
“Biomarkers of periop nivolumab in NSCLC.
- CM77T: nivo=98 pbo=92
- preop ctDNA clearance = Nivo 66% v PBO 38% assoc w pCR
- ctDNAcl+pCR= EFS v no pCR HR 0.29
KEAP1/STK11/CDKN2A/SMARCA4 = PFS HR 0.48 ”
Title: Biomarkers of nivolumab profit in resectable non-small cell lung most cancers
Authors: Tina Cascone, Mark M. Awad, Jonathan D. Spicer, Jie He, Shun Lu, Fumihiro Tanaka, Robin Cornelissen, Lubos B. Petruzelka, Yang Gao, Jean-Louis Pujol, Hiroyuki Ito, Ludmila de Oliveira Muniz Koch, Tudor-Eliade Ciuleanu, Lin Wu, Sabine Bohnet, Yasutaka Watanabe,
Janis M. Taube, Julie Stein Deutsch, Cinthya Coronado Erdmann, Stephanie Meadows-Shropshire, Jaclyn Neely, Virginia Ip, Yu-Han Hung, Padma Sathyanarayana, Sumeena Bhatia, Katherine Chu, Steven I. Blum, Stefano Lucherini, Nathanial Eddy, Akshay Yadav and Mariano Provencio
